Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

DSE antibody (AA 23-270) (FITC)

This anti-DSE antibody is a Rabbit Polyclonal antibody detecting DSE in . Suitable for Human.
Catalog No. ABIN7149748

Quick Overview for DSE antibody (AA 23-270) (FITC) (ABIN7149748)

Target

See all DSE Antibodies
DSE (Dermatan Sulfate Epimerase (DSE))

Reactivity

  • 10
  • 1
Human

Host

  • 5
  • 5
Rabbit

Clonality

  • 6
  • 4
Polyclonal

Conjugate

  • 7
  • 1
  • 1
  • 1
This DSE antibody is conjugated to FITC

Application

Please inquire
  • Binding Specificity

    • 4
    • 1
    • 1
    • 1
    • 1
    AA 23-270

    Purpose

    DSE Antibody, FITC conjugated

    Purification

    Protein G purified

    Purity

    >95 %

    Immunogen

    Recombinant Human Dermatan-sulfate epimerase protein (23-270AA)

    Isotype

    IgG
  • Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4

    Preservative

    ProClin

    Precaution of Use

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    -20 °C,-80 °C

    Storage Comment

    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Target

    DSE (Dermatan Sulfate Epimerase (DSE))

    Alternative Name

    DSE

    Background

    Background: Converts D-glucuronic acid to L-iduronic acid (IdoUA) residues.

    Aliases: Chondroitin glucuronate 5 epimerase antibody, Chondroitin-glucuronate 5-epimerase antibody, Dermatan sulfate epimerase antibody, Dermatan-sulfate epimerase antibody, DS epimerase antibody, DSE antibody, DSE_HUMAN antibody, DSEPI antibody, OTTHUMP00000040406 antibody, SART 2 antibody, SART-2 antibody, Squamous cell carcinoma antigen recognized by T cells 2 antibody, Squamous cell carcinoma antigen recognized by T-cells 2 antibody

    UniProt

    Q9UL01

    Pathways

    Glycosaminoglycan Metabolic Process
You are here:
Chat with us!